D. E. Shaw & Co., Inc. Sarepta Therapeutics, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

  • $125 Billion
  • Q2 2025

Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$17.1 - $63.66 $1.48 Million - $5.51 Million
86,500 New
86,500 $1.48 Million
Q3 2022

Nov 14, 2022
BUY
$75.71 - $119.24 $757,099 - $1.19 Million
10,000 New
10,000 $1.11 Million
Q2 2020

Aug 14, 2020
SELL
$93.0 - $171.7 $6.52 Million - $12 Million
-70,100 Reduced 87.52%
10,000 $1.6 Million
Q1 2020

May 15, 2020
BUY
$82.38 - $131.64 $1.56 Million - $2.49 Million
18,900 Added 30.88%
80,100 $7.84 Million
Q4 2019

Feb 14, 2020
SELL
$76.53 - $135.58 $765,300 - $1.36 Million
-10,000 Reduced 14.04%
61,200 $7.9 Million
Q3 2019

Nov 14, 2019
BUY
$72.81 - $156.91 $4.09 Million - $8.82 Million
56,200 Added 374.67%
71,200 $5.36 Million
Q2 2019

Aug 14, 2019
SELL
$112.21 - $151.95 $33,663 - $45,585
-300 Reduced 1.96%
15,000 $2.28 Million
Q1 2019

May 15, 2019
SELL
$106.67 - $151.68 $2.13 Million - $3.03 Million
-20,000 Reduced 56.66%
15,300 $1.82 Million
Q4 2018

Feb 14, 2019
BUY
$97.32 - $148.76 $3.3 Million - $5.04 Million
33,900 Added 2421.43%
35,300 $3.85 Million
Q3 2018

Nov 14, 2018
SELL
$115.31 - $161.51 $3.36 Million - $4.7 Million
-29,100 Reduced 95.41%
1,400 $226,000
Q3 2017

Nov 14, 2017
BUY
$35.73 - $47.15 $1.09 Million - $1.44 Million
30,500
30,500 $1.38 Million

Others Institutions Holding SRPT

# of Institutions
462
Shares Held
83.3M
Call Options Held
5.6M
Put Options Held
4.19M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $1.98B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email